SANGUI BIOTECH INTERNATIONAL INC (SGBI) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 78 transactions totaling $1.7M, demonstrating a bullish sentiment with $1.3M in net insider flow. The most recent transaction on Oct 13, 2021 involved a sale of 1,200,000 shares valued at $24.0K.
No significant insider buying has been recorded for SGBI in the recent period.
No significant insider selling has been recorded for SGBI in the recent period.
Based on recent SEC filings, insider sentiment for SGBI is bullish with an Insider Alignment Score of 87/100 and a net flow of $1.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at SANGUI BIOTECH INTERNATIONAL INC (SGBI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading SGBI stock, having executed 78 transactions in the past 90 days. The most active insider is Hubertus Schmelz (Executive), who has made 27 transactions totaling $1.3M.
Get notified when executives and directors at SGBI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 13, 2021 | Schmelz Hubertus | Executive | Sale | 1,200,000 | $0.02 | $24.0K | |
| Jan 23, 2018 | Schmelz Hubertus | Executive | Purchase | 85,000 | $0.04 | $3.4K | |
| Nov 14, 2017 | Schmelz Hubertus | Executive | Purchase | 20,000 | $0.04 | $800 | |
| Nov 13, 2017 | Schmelz Hubertus | Executive | Purchase | 91,000 | $0.04 | $3.6K | |
| Oct 11, 2017 | Schmelz Hubertus | Executive | Purchase | 1,190,000 | $0.03 | $35.7K | |
| Sep 21, 2017 | Schmelz Hubertus | Executive | Purchase | 1,190,000 | $0.03 | $35.7K | |
| Aug 8, 2017 | Schmelz Hubertus | Executive | Purchase | 50,000 | $0.04 | $2.0K | |
| Aug 3, 2017 | Schmelz Hubertus | Executive | Purchase | 1,190,000 | $0.03 | $35.7K | |
| Aug 2, 2017 | Schmelz Hubertus | Executive | Purchase | 60,000 | $0.04 | $2.4K | |
| Aug 2, 2017 | Schmelz Hubertus | Executive | Purchase | 41,875 | $0.04 | $1.7K | |
| Aug 2, 2017 | Schmelz Hubertus | Executive | Purchase | 42,000 | $0.04 | $1.7K | |
| May 26, 2017 | Schmelz Hubertus | Executive | Purchase | 49,425 | $0.04 | $2.0K | |
| May 24, 2017 | Schmelz Hubertus | Executive | Purchase | 50,000 | $0.04 | $2.0K | |
| Dec 27, 2016 | Schmelz Hubertus | Executive | Purchase | 80,800 | $0.04 | $3.2K | |
| Oct 20, 2016 | Schmelz Hubertus | Executive | Purchase | 100,000 | $0.03 | $3.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 14 | $2.3M | 56.1% |
Purchase(P) | 37 | $1.5M | 37.4% |
Sale(S) | 18 | $220.4K | 5.4% |
Payment(F) | 2 | $43.5K | 1.1% |
Gift(G) | 7 | $0 | 0.0% |
Insiders at SANGUI BIOTECH INTERNATIONAL INC are accumulating shares at an accelerated pace. With 11 insiders making 78 transactions totaling $1.5M in purchases versus $220.4K in sales, the net buying activity of $1.3M signals strong executive confidence. Hubertus Schmelz (Executive) leads the buying activity with $1.3M in transactions across all time.